Skip to Main Content

Paper Details

SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors With Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome.
Am J Surg Pathol
2
2022
AT, AT/RT, AT/RTs, Atypical teratoid/rhabdoid tumor, IDH, Li-Fraumeni Syndrome, Li-Fraumeni syndrome, Malignant gliomas, SMARCA4, SMARCA4 deficiency, SMARCA4 protein, SMARCB1, SMARCB1 deficiency, SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors, SMARCB1-deficient or SMARCA4-deficient malignant brain tumors, TP53, TP53 Mutations, TP53 variants, central nervous system tumors, children, germline, infants, malignant central nervous system tumor, malignant supratentorial brain tumors, patients
Author NameAffiliation
Pascal D JohannHopp Children's Cancer Center (KiTZ).
Pascal D JohannSwabian Childrens' Cancer Center, University Hospital Augsburg and EU-RHAB Registry.
Pascal D JohannGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK).
Kristian W PajtlerHopp Children's Cancer Center (KiTZ).
Kristian W PajtlerUniversity Hospital Heidelberg.
Kristian W PajtlerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK).
Kristian W PajtlerHopp Children's Cancer Center (KiTZ).
Kristian W PajtlerGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK).
Kristian W PajtlerUniversity Hospital Heidelberg.
Christian MawrinOtto von Guericke University Magdeburg
Ulrich Sch??llerUniversity Medical Center Hamburg-Eppendorf.
Ulrich Sch??llerInstitute of Neuropathology, University Medical Center Hamburg-Eppendorf, and Research Institute Children's Cancer Center Hamburg
Christof M KrammUniversity Medical Center Gottingen
Felix SahmInstitute of Pathology, University Hospital Heidelberg
Felix SahmInstitute of Pathology, University Hospital Heidelberg
Caterina GianniniMayo Clinic
Caterina GianniniMayo Clinic
Christian P KratzHannover Medical School
Stefan M PfisterHopp Children's Cancer Center (KiTZ).
Stefan M PfisterUniversity Hospital Heidelberg.
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK).
Stefan M PfisterHopp Children's Cancer Center (KiTZ).
Stefan M PfisterGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK).
Stefan M PfisterUniversity Hospital Heidelberg.
Reiner SiebertInstitute of Human Genetics, Ulm University and Ulm University Medical Center
Marcel KoolHopp Children's Cancer Center (KiTZ).
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK).
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolHopp Children's Cancer Center (KiTZ).
Marcel KoolGerman Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK).
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Michael C FrühwaldSwabian Childrens' Cancer Center, University Hospital Augsburg and EU-RHAB Registry.
  • 1 - 32

Datasets

Release 1.2